Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data

Published:2018-10-20 Issue:3 Volume:125 Page:406-415
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Bauml Joshua M.¹²,Vinnakota Ravi³,Anna Park Yeun‐Hee³⁴,Bates Susan E.³⁴,Fojo Tito³⁴,Aggarwal Charu²,Di Stefano Jessica¹,Knepley Christina²,Limaye Sewanti³,Mamtani Ronac²,Wisnivesky Juan⁵,Damjanov Nevena¹²,Langer Corey J.²,Cohen Roger B.²,Sigel Keith³⁵^ORCID

Affiliation:

1. Michael J. Crescenz Veterans Affairs Medical Center Philadelphia Pennsylvania

2. Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania

3. James J. Peters Veterans Affairs Medical Center Bronx New York

4. College of Physicians and Surgeons at Columbia University New York New York

5. Mount Sinai School of Medicine New York New York

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.31816

Reference31 articles.

1. Cancer statistics, 2017

2. An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer

3. Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

4. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

5. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse Event Profile and Compliance of Docetaxel with Radiation in Cisplatin-Ineligible Patients of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Research Protocol;JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH;2024

2. Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients;Oral Oncology;2023-08

3. Deployment of cisplatin in Veterans with oropharyngeal cancer: toxicity and impact on oncologic outcomes;Laryngoscope Investigative Otolaryngology;2023-07-14

4. Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma;International Journal of Molecular Sciences;2023-03-18

5. Radiotherapy Plus Cetuximab for Squamous Cell Carcinoma of the Oral Cavity: A Multicenter Retrospective Study of 79 Patients in Japan;International Journal of Environmental Research and Public Health;2023-03-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3